[1. V. M. Lakshmi, F. F. Hsu and T. V. Zenser, 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline stability and reactivity, Chem. Res. Toxicol. 17 (2004) 709-716; DOI: 10.1021/tx030042b.10.1021/tx030042b]Search in Google Scholar
[2. M. M. Ghorab, A. M. El-Sherief, Y. A. Ammar and S. I. Mohamed, Synthesis and radiation stability of novel biologically active sulfur compounds derived from 1,2-bis(4-amino-5-mercapto-striazol-3-yl)ethane, Farmaco 55 (2000) 354-361.10.1016/S0014-827X(00)00051-3]Search in Google Scholar
[3. M. M. Ghorab, F. A. Ragab and M. M. Hamed, Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety, Eur. J. Med. Chem. 44 (2009) 4211-4217; DOI: 10.1016/j.ejmech.2009.05.017.10.1016/j.ejmech.2009.05.01719540022]Search in Google Scholar
[4. S. Mathan, K. Chandraprakash, C. Uvarani and S. M. Palathurai, Synthesis, antioxidant and toxicological study of novel pyrimido quinoline derivatives from 4-hydroxy-3-acyl quinolin-2-one, Bioorg. Med. Chem. Lett. 20 (2010) 7147-7151; DOI: 10.1016/j.bmcl.2010.09.018.10.1016/j.bmcl.2010.09.01820947350]Search in Google Scholar
[5. V. G. Brunton, M. J. Lear, P. Mckeown, D. J. Robins and P. Workman, Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties, Anticancer Drug Res. 11 (1996) 463-483.]Search in Google Scholar
[6. E. W. Chia, A. N. Pearce, M. V. Berridge, L. Larsen, N. B. Perry, C. E. Sansom, C. A. Godfrey, L. R. Hanton, G. L. Lu, M. Walton, W. A. Denny, V. L. Webb, B. R. Copp and J. L. Harper, Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: Inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis, Bioorg. Med. Chem. 16 (2008) 9432-9442; DOI: 10.1016/j.bmc.2008.09.052.10.1016/j.bmc.2008.09.05218835721]Search in Google Scholar
[7. V. R. Solomon and H. Lee, Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies, Eur. J. Pharmacol. 625 (2009) 220-233; DOI: 10.1016/j.ejphar.2009.06.063.10.1016/j.ejphar.2009.06.06319836374]Search in Google Scholar
[8. I. Perković, S. Tršinar, J. Žanetić, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A. M. Katsori and B. Zorc, Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies, J. Enzyme Inhib. Med. Chem. 28 (2013) 601-610; DOI: 10.3109/14756366.2012.663366.10.3109/14756366.2012.66336622380782]Search in Google Scholar
[9. A. S. Abel, A. D. Averin, O. A. Maloshitskaya, E. N. Savelyev, B. S. Orlinson, I. A. Novakov and I. P. Beletskaya, Palladium-catalyzed amination of dichloroquinolines with adamantane-containg amines, Molecules 18 (2013) 2096-2109; DOI: 10.3390/molecules18022096.10.3390/molecules18022096627035723389254]Search in Google Scholar
[10. N. Amit, M. Vikramdeep, M. Alpeshkumar, C. Evans and J. Rahul, Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines, Bioorg. Med. Chem. 15 (2007) 626-640; DOI: 10.1016/j.bmc.2006.10.064.10.1016/j.bmc.2006.10.06417107805]Search in Google Scholar
[11. M. S. Al-Said, M. M. Ghorab and M. Y. Nissan, Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1,3-dihydropyridine, chromene and chromenopyridine moieties, Chem. Cent. J. 6 (2012) Article No. 64; DOI: 10.1186/1752-153X-6-64.10.1186/1752-153X-6-64354339122748424]Search in Google Scholar
[12. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660-670; DOI: 10.1007/s12272-013-0094-6.10.1007/s12272-013-0094-623529860]Search in Google Scholar
[13. M. S. Al-Dosari, M. M. Ghorab, M. S. Al-Said and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50-58; DOI: org/10.1248/cpb.c12-00812.10.1248/cpb.c12-0081223302586]Search in Google Scholar
[14. M. S. Al-Said, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneim. Forsch. 61 (2011) 527-531; DOI: 10.1055/s-0031-1296239.10.1055/s-0031-129623922029230]Search in Google Scholar
[15. M. S. Bashandy, M. S. Alsaid, S. I. Alqasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity, Arzneim. Forsch. 61 (2011) 521-526; DOI: 10.1055/s-0031-1296238.10.1055/s-0031-129623822029229]Search in Google Scholar
[16. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocycl. Chem. 48 (2011) 563-571; DOI: 10.1002/jhet.619.10.1002/jhet.619]Search in Google Scholar
[17. M. S. Al-Said, M. S. Bashandy, S. I. Alqasomi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137-141; DOI: 10.1016/j.ejmech.2010.10.024.10.1016/j.ejmech.2010.10.02421093116]Search in Google Scholar
[18 M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res. 20 (2011) 388-400; DOI: 10.1007/s00044-010-9332-3.10.1007/s00044-010-9332-3]Search in Google Scholar
[19. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107. 10.1093/jnci/82.13.11072359136]Search in Google Scholar